Related Experiment Videos
The role of catecholamines and opiate peptides with particular reference to the striatum
Applied Neurophysiology
|January 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Basis of the gabamimetic profile of ethanol.
Alcoholism, clinical and experimental research·2006
Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.
The Journal of neuroscience : the official journal of the Society for Neuroscience·2001
Ethanol inhibition of N-methyl-D-aspartate responses involves presynaptic gamma-aminobutyric acid(B) receptors.
The Journal of pharmacology and experimental therapeutics·2000
A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus.
Proceedings of the National Academy of Sciences of the United States of America·2000
Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus.
Proceedings of the National Academy of Sciences of the United States of America·2000
Ethanol enhances gamma-aminobutyric acid responses in a subpopulation of nucleus accumbens neurons: role of metabotropic glutamate receptors.
The Journal of pharmacology and experimental therapeutics·2000
Evaluation of laser- and radiofrequency-generated dorsal root entry zone lesions in the cat.
Applied neurophysiology·1988
Pain control with laser-produced dorsal root entry zone lesions.
Applied neurophysiology·1988
Radiofrequency lesion generation and its effect on tissue impedance.
Applied neurophysiology·1988
Anatomic examination of human dorsal root entry zone lesions.
Applied neurophysiology·1988
The Laws of Bariatric Pheromonology.
JPMA. The Journal of the Pakistan Medical Association·2026
Poisons causing acute kidney injury in Indo-Pak region: A meta-analysis.
JPMA. The Journal of the Pakistan Medical Association·2026
Choroid Plexus Microstructural Alterations Link Glymphatic Dysfunction and White Matter Degeneration in Parkinson's Disease.
CNS neuroscience & therapeutics·2026